Humana's share price jumped after the Trump administration rolled out new initiatives on kidney care, according to Louisville Business First.
After President Donald Trump signed an executive order to transform kidney treatment in the U.S., Humana's stock price increased to $291.28 July 12. At market close July 12, Humana's share price was up 10 percent from its closing share on July 8.
The share price marked Humana's highest gain since Feb. 26, when the price closed at $302.35. That high came at the end of a historic run for the company's shares, according to Louisville Business First.
Read the full report here.
More articles on payers:
UnitedHealth needs to shore up mental health coverage, plaintiffs argue
Las Vegas hospital will have to contract with Medicare, Medicaid by 2021
Massachusetts residents bought fake health insurance, state says